心源性脑栓塞合并多种基础病患者药物治疗实践  

Pharmaceutical Practice of Patients with Cardiogenic Cerebral Embolism with Multiple Underlying Diseases

作　　者：付文艳 叶金华 万瑾瑾 廖辉军 梁佳[1] FU Wenyan;YE Jinhua;WAN Jinjin;LIAO Huijun;LIANG Jia(The Second Affiliated Hospital of Nanchang University,Nanchang Jiangxi 330006,China;Jiangxi Provincial Drug Administration,Nanchang Jiangxi 330029,China)

机构地区：[1]南昌大学第二附属医院,江西南昌330006 [2]江西省药品监督管理局,江西南昌330029

出　　处：《药品评价》2023年第1期124-126,共3页Drug Evaluation

摘　　要：目的通过对1例心源性脑栓塞合并肾功能不全及糖尿病患者抗栓药物选择及治疗过程监护,探讨临床药师在特殊患者药物治疗中作用。方法临床药师参与特殊患者药物治疗过程,结合循证对患者抗栓治疗提供个体化建议,当患者出现药源性低血糖时,协助医生及时调整药物治疗方案。结果医生采纳药师药物建议,患者治疗过程未再出现药源性事件。结论临床药师参与特殊患者药物治疗过程对提高治疗效果减少药源性疾病发生具有重要意义。Objective To explore the role of clinical pharmacists in antithrombotic therapy by drug selection and providing pharmaceutical care for the patients with cardiogenic cerebral embolism with kidney diseases and diabetes.Methods Clinical pharmacists participate in pharmacotherapy process for specific patients,individualized advice to patients combined with evidence-based basis.The glucose-lowering drug plan was timely adjusted when the patient occured drug-induced hypoglycemia.Results Clinical pharmacists adopted the pharmacist's drug advice,and no drug-induced events occurred during the treatment.Conclusion It is significance for clinical pharmacists to actively participate in clinical treatment programs to improve the treatment effect and reduce the occurrence of drug-induced disease.

关 键 词：颅内栓塞 药学服务 抗栓治疗 肾功能不全 药源性低血糖 

分 类 号：R969.3[医药卫生—药理学]